226 related articles for article (PubMed ID: 26735889)
1. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract][Full Text] [Related]
2. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
4. Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.
Nabavi S
BMC Genomics; 2016 Aug; 17(1):638. PubMed ID: 27526849
[TBL] [Abstract][Full Text] [Related]
5. Driver pattern identification over the gene co-expression of drug response in ovarian cancer by integrating high throughput genomics data.
Lu X; Lu J; Liao B; Li X; Qian X; Li K
Sci Rep; 2017 Nov; 7(1):16188. PubMed ID: 29170526
[TBL] [Abstract][Full Text] [Related]
6. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
7. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
[TBL] [Abstract][Full Text] [Related]
8. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
9. Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer.
Zhao L; Wang W; Xu L; Yi T; Zhao X; Wei Y; Vermeulen L; Goel A; Zhou S; Wang X
Oncogene; 2019 Mar; 38(13):2305-2319. PubMed ID: 30478449
[TBL] [Abstract][Full Text] [Related]
10. Depicting the genetic architecture of pediatric cancers through an integrative gene network approach.
Savary C; Kim A; Lespagnol A; Gandemer V; Pellier I; Andrieu C; Pagès G; Galibert MD; Blum Y; de Tayrac M
Sci Rep; 2020 Jan; 10(1):1224. PubMed ID: 31988326
[TBL] [Abstract][Full Text] [Related]
11. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
[TBL] [Abstract][Full Text] [Related]
12. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
Wang X; Wang SS; Zhou L; Yu L; Zhang LM
J Ovarian Res; 2016 Nov; 9(1):73. PubMed ID: 27806724
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
14. Matrix factorization methods for integrative cancer genomics.
Zhang S; Zhou XJ
Methods Mol Biol; 2014; 1176():229-42. PubMed ID: 25030932
[TBL] [Abstract][Full Text] [Related]
15. Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data.
Zhang T; Xu J; Deng S; Zhou F; Li J; Zhang L; Li L; Wang QE; Li F
PLoS One; 2018; 13(5):e0196351. PubMed ID: 29723215
[TBL] [Abstract][Full Text] [Related]
16. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
17. Identifying master regulators of cancer and their downstream targets by integrating genomic and epigenomic features.
Gevaert O; Plevritis S
Pac Symp Biocomput; 2013; ():123-34. PubMed ID: 23424118
[TBL] [Abstract][Full Text] [Related]
18. Integrative network analysis to identify aberrant pathway networks in ovarian cancer.
Chen L; Xuan J; Gu J; Wang Y; Zhang Z; Wang TL; Shih IeM
Pac Symp Biocomput; 2012; ():31-42. PubMed ID: 22174260
[TBL] [Abstract][Full Text] [Related]
19. Identifying multi-layer gene regulatory modules from multi-dimensional genomic data.
Li W; Zhang S; Liu CC; Zhou XJ
Bioinformatics; 2012 Oct; 28(19):2458-66. PubMed ID: 22863767
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Integration of Multi-omics Data Improves the Identification of Cancer Driver Modules.
Silverbush D; Cristea S; Yanovich-Arad G; Geiger T; Beerenwinkel N; Sharan R
Cell Syst; 2019 May; 8(5):456-466.e5. PubMed ID: 31103572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]